Yes, it is only be studied for asthma. It may be used for other
> indications later on, but this product will probably be quite
> expensive as it is a biotechnology produced protein. It's not going
> to be anywhere near as cheap as the antihistamines that are presently
> on the market.
>
> Health insurers will only pay for the labeled indication.
>
> Alan
James here....
Correct, my doc said there was not way my HMO would pay for it unless I had
the Dx of Asthma. Of course they are happy to pump me full of prednisone,
which is cheap. Neither my doc nor I are real happy using cortisone very
often, though.
James
|
